Selective bladder-preserving therapy for muscle-invasive cancer
Authors:
- Donald S. KaufmanDKDonald S. Kaufman
- William U. ShipleyWSWilliam U. Shipley
- 1 April 2009
- journal article
- Published by Springer Nature in Nature Reviews Clinical Oncology
- Vol. 6 (4) , 193-194
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Phase I-II RTOG Study (99-06) of Patients With Muscle-Invasive Bladder Cancer Undergoing Transurethral Surgery, Paclitaxel, Cisplatin, and Twice-daily Radiotherapy Followed by Selective Bladder Preservation or Radical Cystectomy and Adjuvant ChemotherapyUrology, 2009
- Organ Conservation in Invasive Bladder Cancer by Transurethral Resection, Chemotherapy and Radiation: Results of a Urodynamic and Quality of Life Study on Long-term SurvivorsJournal of Urology, 2003
- Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerNew England Journal of Medicine, 2003
- Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancerUrology, 2002
- Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladderUrology, 2001
- COMBINATION CISPLATIN, 5-FLUOROURACIL AND RADIATION THERAPY FOR LOCALLY ADVANCED UNRESECTABLE OR MEDICALLY UNFIT BLADDER CANCER CASES: A SOUTHWEST ONCOLOGY GROUP STUDYJournal of Urology, 2001
- Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03.Journal of Clinical Oncology, 1998
- Full-Dose Irradiation for Patients with Invasive Bladder Carcinoma: Clinical and Histological Factors Prognostic of Improved SurvivalJournal of Urology, 1985